Who is sponsoring NCT05242952?

NCT05242952 is sponsored by Yale University.

What drugs are being tested in NCT05242952?

Interventions in NCT05242952: Gaming in a virtual environment.

What condition does NCT05242952 study?

NCT05242952 studies Cardiovascular Diseases.

Is NCT05242952 still recruiting?

NCT05242952 is currently completed. Last updated 28 July 2025.

Last reviewed 2025-07-28 · How we verify

NCT05242952: LEARN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The LEARN Study for CVD Prevention

Completed NA Last updated 28 July 2025

What this trial tests

NA trial testing Gaming in a virtual environment in Cardiovascular Diseases in 78 participants. Completed in 31 March 2025.

Timeline

10 May 2023

Primary endpoint
31 March 2025

31 March 2025

Quick facts

Lead sponsor	Yale University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	78
Start date	10 May 2023
Primary completion	31 March 2025
Estimated completion	31 March 2025
Sites	1 location across United States

Drugs / interventions tested

Gaming in a virtual environment

Conditions studied

Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

Yale University

Who can join

Adults 30 to 65, male only, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigator is testing a virtual environment to address prevention of HIV-related comorbidities.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Cardiovascular Disease Prevention Education Using a Virtual Environment in Sexual-Minority Men of Color With HIV: Protocol for a Sequential, Mixed Method, Waitlist Randomized Controlled Trial.
Ramos SR, Johnson C, Melkus G, Kershaw T, et al · · 2022 · cited 6× · PMID 35579928 · DOI 10.2196/38348
Perceptions of HIV-Related Comorbidities and Usability of a Virtual Environment for Cardiovascular Disease Prevention Education in Sexual Minority Men With HIV: Formative Phases of a Pilot Randomized Controlled Trial.
Ramos SR, Reynolds H, Johnson C, Melkus G, et al · · 2024 · cited 4× · PMID 38924481 · DOI 10.2196/57351
A Web-based Virtual Environment Behavioral Intervention as CVD and Metabolic Disease Prevention Education in Persons with HIV: Evaluation of the LEARN RCT.
Ramos SR, Boerger L, Restar AJ, Phadke M, et al · · 2026 · PMID 42154285 · DOI 10.2196/91145

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Yale University trials

Trials by the same sponsor.

NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05242952 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 28 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05242952.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing